The Tissue Expanders Market valued for $671.5 million in 2021 and is estimated to reach $1,180.0 million by 2031, exhibiting a CAGR of 5.8% from 2022 to 2031. Tissue expanders are balloons made of silicon and filler ingredients, molded into a pre-shaped prosthesis, which can be filled with saline through a valve system, which is either incorporated on the expander's surface (early expanders had this structure which is not seen nowadays) or is remote and connected by a flexible silastic filling tube to the expander (nearly all expanders nowadays have a remote valve). The main benefit of the remote valve and filling tube is that it keeps the injection point far from the balloon, eliminating any potential hazards of balloon puncture during expander inflation. Remote positioning enables placing at a location beneath the skin where it can be felt readily.
The growth of tissue expanders market is driven by technological advancement for development of different tissue expanders and rise in the prevalence of breast cancer. In addition, increase in number of various Strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. Breast cancer is the most common type of cancer in women and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of extremity tissue expanders for breast reconstruction. Thus, rise in number of female patients suffering from breast cancer is anticipated to drive the demand for tissue expanders and fuel the market growth.
Rise in the adoption of minimally invasive procedure for improvement of aesthetic appearance is expected to drive the demand for tissue expanders and boost the market growth. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, it was reported that, approximately 10,129,528 cosmetic procedures were performed by plastic surgeons worldwide. Tissue expanders are used for scalp reconstruction, breast reconstruction, oral & maxillofacial reconstruction, and to repair burn scars. Thus, rise in number of burn injuries and oral & maxillofacial deformity lead to upsurge in demand for tissue expanders.
In addition, the Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, & security of human & veterinary drugs, biological products, and medical devices. Rise in product approval for tissue expanders by Food and Drug Administration (FDA) is anticipated to drive the growth of tissue expanders market. For instance, in October 2022, according to Food and Drug Administration, it was reported that, the FDA has cleared 48 tissue expanders and accessories.
In addition, rise in expenditure by governments to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals and clinics. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for tissue expanders for reconstructive procedures, thereby boosting the market growth.
On the other hand, high cost of treatment and side effects of the tissue expansion procedures are some factors that are anticipated to restrain the growth of the tissue expanders market.
The tissue expanders market is segmented on the basis of lesion site, product shape, application, end user, and region. By product type, the market is fragmented into lower extremity, upper extremity, and others. The others segment is further divided into trunk, back, and head. By product shape, the market is categorized into rectangular, crescent, round, and others. The others segment is further divided into anatomical, elliptical, and cylindrical. On the basis of application, the market is classified into breast reconstruction, facial reconstruction, and others. The others segment is further divided into congenital disorders, burn scar, and scalp reconstruction. By end user, the market is fragmented into hospitals, cosmetic clinics, and others. The others segment is further bifurcated into ambulatory surgical centers and burn center. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global tissue expanders market include GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Establishment Labs, and Silimed.
The growth of tissue expanders market is driven by technological advancement for development of different tissue expanders and rise in the prevalence of breast cancer. In addition, increase in number of various Strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. Breast cancer is the most common type of cancer in women and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of extremity tissue expanders for breast reconstruction. Thus, rise in number of female patients suffering from breast cancer is anticipated to drive the demand for tissue expanders and fuel the market growth.
Rise in the adoption of minimally invasive procedure for improvement of aesthetic appearance is expected to drive the demand for tissue expanders and boost the market growth. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, it was reported that, approximately 10,129,528 cosmetic procedures were performed by plastic surgeons worldwide. Tissue expanders are used for scalp reconstruction, breast reconstruction, oral & maxillofacial reconstruction, and to repair burn scars. Thus, rise in number of burn injuries and oral & maxillofacial deformity lead to upsurge in demand for tissue expanders.
In addition, the Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, & security of human & veterinary drugs, biological products, and medical devices. Rise in product approval for tissue expanders by Food and Drug Administration (FDA) is anticipated to drive the growth of tissue expanders market. For instance, in October 2022, according to Food and Drug Administration, it was reported that, the FDA has cleared 48 tissue expanders and accessories.
In addition, rise in expenditure by governments to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals and clinics. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for tissue expanders for reconstructive procedures, thereby boosting the market growth.
On the other hand, high cost of treatment and side effects of the tissue expansion procedures are some factors that are anticipated to restrain the growth of the tissue expanders market.
The tissue expanders market is segmented on the basis of lesion site, product shape, application, end user, and region. By product type, the market is fragmented into lower extremity, upper extremity, and others. The others segment is further divided into trunk, back, and head. By product shape, the market is categorized into rectangular, crescent, round, and others. The others segment is further divided into anatomical, elliptical, and cylindrical. On the basis of application, the market is classified into breast reconstruction, facial reconstruction, and others. The others segment is further divided into congenital disorders, burn scar, and scalp reconstruction. By end user, the market is fragmented into hospitals, cosmetic clinics, and others. The others segment is further bifurcated into ambulatory surgical centers and burn center. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global tissue expanders market include GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Establishment Labs, and Silimed.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tissue expanders market analysis from 2021 to 2031 to identify the prevailing tissue expanders market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the tissue expanders market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global tissue expanders market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Lesion Site
- Lower Extremity
- Upper Extremity
- Application
- Breast reconstruction
- Facial reconstruction
By Product Shape
- Rectangular
- Crescent
- Round
By End User
- Hospitals
- Cosmetic Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbvie Inc
- Johnson & Johnson
- Groupe Sebbin SAS
- Sientra, Inc.
- PMT Corporation
- Establishment Labs
- Silimed
- POLYTECH Health & Aesthetics GmbH
- Guangzhou Wanhe Plastic Materials Co. Ltd
- GC Aesthetics PLC
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: TISSUE EXPANDERS MARKET, BY LESION SITE
CHAPTER 5: TISSUE EXPANDERS MARKET, BY PRODUCT SHAPE
CHAPTER 6: TISSUE EXPANDERS MARKET, BY END USER
CHAPTER 7: TISSUE EXPANDERS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, 'Tissue Expanders Market,' the tissue expanders market was valued at $671.46 million in 2021, and is estimated to reach $1,180.0 million by 2031, growing at a CAGR of 5.8% from 2022 to 2031. Tissue expansion is a method that is used by plastic and reconstructive surgeons to help the body grow new skin, bone, or other tissues. It is commonly used in adults and children for skin reconstruction. Also, the technique is utilized in the treatment of burns and scars and other congenital disabilities. There are two types of products which includes lower extremity and upper extremity. Based on the shape of product there are three types of products which includes rectangular, crescent, and round. Application of the tissue expander is for scalp reconstruction, breast reconstruction, oral and maxillofacial reconstruction, and others. End user for tissue expanders are hospitals, cosmetic clinics, and other.Key factors driving the growth of the Tissue expanders market include increase in the number of minimally invasive surgeries, rise in the prevalence of breast cancer, rise in prevalence of breast cancer and increase in the awareness regarding cosmetic surgeries. Rise in prevalence of burn injuries, facial injuries are anticipated to drive the demand for tissue expanders for reconstructive surgeries. Thus, this factor is anticipated to drive the growth of tissue expander market. In addition, rise in number of burn repair reconstructive procedure are anticipated to drive the growth of market. For instance, according to American Society of Plastic Surgery, in 2019, it was reported that 25,854 burn repair procedures were performed in U.S. In addition, as per the same source, it was reported that, in 2020, around 256,085 maxillofacial surgeries performed in U.S. Thus, this factor is attributed to drive demand for rectangular tissue expanders and fuels the market growth. Increase in the awareness among the people regarding availability of cosmetic surgeries for improving aesthetic appearance are anticipated to drive the growth of tissue expanders market. Tissue expanders are used for scar removal, burn repair and others. Thus, rise in the prevalence of burn injuries are anticipated to drive the demand for tissue expanders and fuels the growth of market.
The market also offers growth opportunities to the key players in the market. Increase in the number of product launch and product approvals for tissue expanders drives the market growth. For instance, in September 2021, Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women's health and wellness, launched Motiva Flora tissue expander in Europe and other Conformité Européenne (CE) Mark countries.
The tissue expanders market is segmented based on lesion site, product shape, application, end user and region. Based in product type the market is segmented into lower extremity, upper extremity and others. Based in product shape the market is bifurcated into rectangular, crescent, round, and others. Based on application the market is segmented into breast reconstruction, facial reconstruction, and others. Based on end user the market is segmented into hospitals, cosmetic clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Gmb, Establishment Labs, Silimed. The players in the market have been actively engaged in the adoption various Strategies such as acquisition, product launch and expansion to remain competitive and gain advantage over the competitors in the market. For instance, in November 2022, Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women's health and wellness, received approved for Motiva Implants and the Motiva Flora tissue expander for use in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA). Its surface technology as well as a RFID-enabled, non-magnetic integrated port, offers potential improvements in imaging, treatment, and overall clinical outcomes and patient satisfaction.
Key Market Insights
By lesion type, the lower extremity segment was the highest revenue contributor to the market and is estimated to reach $284.4 million by 2031, with a CAGR of 5.4%. However, the others segment is estimated to be the fastest-growing segment with a CAGR of 6.0% during the forecast period.By product shape, the rectangular segment dominated the global market. However, the same segment is expected to be the fastest-growing segment with a CAGR of 6.1% during the forecast period.
Based on end user, the hospitals segment was the highest revenue contributor to the market with a CAGR of 6.3% during the forecast period.
Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 6.9% during the forecast period
Companies Mentioned
- Abbvie Inc
- Johnson & Johnson
- Groupe Sebbin SAS
- Sientra, Inc.
- PMT Corporation
- Establishment Labs
- Silimed
- POLYTECH Health & Aesthetics GmbH
- Guangzhou Wanhe Plastic Materials Co. Ltd
- GC Aesthetics PLC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
From
Tissue Expander Market by Product, Application, End-User - Global Forecast 2025-2030
- Report
- 195 Pages
- Global
From
Tissue Expanders - Global Strategic Business Report
- Report
- 89 Pages
- Global
From
Breast Tissue Expander Market 2024-2028
- Report
- 158 Pages
- Global
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
